TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive In Brief: ACS Estimates 502,000 U.S. Cancer Deaths, 178,000 Avoidable With Early Diagnosis March 17, 1989
TCL Archive HHS System Of Misconduct investigation Not Suited For Clinical Trials, Broder Says November 11, 1994
TCL Archive Also In sudden policy change, NIH proposes one-year ban on consulting by employees. October 1, 2004
TCL Archive Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax. November 9, 2001
